- Home
- WIW vs THW Comparison
WIW vs THW Comparison
Compare WIW & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | WIW | THW |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Finance Companies |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 518.8M | 513.9M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | WIW | THW |
|---|---|---|
| Price | $8.59 | $12.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 252.7K | 88.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 11.14% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.33 | $10.10 |
| 52 Week High | $9.03 | $13.19 |
Technical Indicators
Market Signals| Indicator | WIW | THW |
|---|---|---|
| Relative Strength Index (RSI) | 57.68 | 63.19 |
| Support Level | $8.56 | $12.33 |
| Resistance Level | $8.84 | $12.95 |
| Average True Range (ATR) | 0.06 | 0.27 |
| MACD | 0.02 | 0.12 |
| Stochastic Oscillator | 94.48 | 94.70 |
Price Performance
Historical ComparisonAbout WIW Western Asset Inflation-Linked Opportunities & Income Fund
Western Asset Inflation-Linked Opportunities and Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income. Capital appreciation, when consistent with current income, is a secondary investment objective. The fund operates as a single operating segment, which is an investment portfolio.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.